×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Harmonizing Regulatory Science Through the International Council for Harmonization (ICH)
Session Chair(s)
Camille Jackson
Director, Regulatory Policy; Legal and Regulatory
Flatiron Health , United States
This session will provide an overview of the ICH Association and offer insight into strategic, long-term views on advancing global convergence of regulatory science through ICH.
Learning Objective : Identify the value and benefits of global regulatory harmonization and the ICH; Discuss opportunities to advance regulatory science through ICH; Describe the current harmonization initiatives that are currently underway and the impact on global drug development.
Speaker(s)
FDA Update
Theresa Mullin, PhD
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
EMA Update
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
MHLW Update
Naoyuki Yasuda, MSc
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director , Office of International Programs
Have an account?